Clinical outcomes of allogeneic hematopoietic stem cell transplant with different stem cell sources in infant acute myeloid leukemia

Abstract Acute Myeloid Leukemia (AML) in infants constitutes a rare and biologically distinct subgroup. Hematopoietic stem cell transplantation (HSCT) plays a pivotal role in the treatment of infant AML. However, the source of stem cells remains insufficiently explored. This study aimed to evaluate...

Full description

Bibliographic Details

Published in:	Scientific Reports
Main Authors:	Yuyang Wang, Yibing Guo, Xiuxin Ling, Junhui Li, Tao Hu, Zhaoxia Zhang, Mengze Hu, Zeliang Song, Mei Yue, Ruihong Tang, Dixiao Zhong, Rong Liu
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-07-01
Subjects:	Hematopoietic stem cell transplantation Acute myeloid leukemia Survival Recurrence rates
Online Access:	https://doi.org/10.1038/s41598-025-05602-z